Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells

被引:71
作者
Jia, HY
Bagherzadeh, A
Bicknell, R
Duchen, MR
Liu, D
Zachary, I
机构
[1] UCL, Rayne Inst, Dept Med, London WC1E 6JJ, England
[2] Univ Oxford, Inst Mol Med, Canc Res UK, Oxford, England
[3] UCL, Dept Physiol, London WC1E 6BT, England
关键词
D O I
10.1074/jbc.M401538200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor (VEGF)-D binds to VEGF receptors (VEGFR) VEGFR2/KDR and VEGFR3/Flt4, but the signaling mechanisms mediating its biological activities in endothelial cells are poorly understood. Here we investigated the mechanism of action of VEGF-D, and we compared the signaling pathways and biological responses induced by VEGF-D and VEGF-A in endothelial cells. VEGF-D induced KDR and phospholipase C-gamma tyrosine phosphorylation more slowly and less effectively than VEGF-A at early times but had a more sustained effect and was as effective as VEGF-A after 60 min. VEGF-D activated extracellular signal-regulated protein kinases 1 and 2 with similar efficacy but slower kinetics compared with VEGF-A, and this effect was blocked by inhibitors of protein kinase C and mitogen-activated protein kinase kinase. In contrast to VEGF-A, VEGF-D weakly stimulated prostacyclin production and gene expression, had little effect on cell proliferation, and stimulated a smaller and more transient increase in intracellular [Ca(2+)]. VEGF-D induced strong but more transient phosphatidylinositol 3-kinase (PI3K)-mediated Akt activation and increased PI3K-dependent endothelial nitric-oxide synthase phosphorylation and cell survival more weakly. VEGF-D stimulated chemotaxis via a PI3K/Akt- and endothelial nitric-oxide synthase-dependent pathway, enhanced protein kinase C- and PI3K-dependent endothelial tubulogenesis, and stimulated angiogenesis in a mouse sponge implant model less effectively than VEGF-A. VEGF-D-induced signaling and biological effects were blocked by the KDR inhibitor SU5614. The finding that differential KDR activation by VEGF-A and VEGF-D has distinct consequences for endothelial signaling and function has important implications for understanding how multiple ligands for the same VEGF receptors can generate ligand-specific biological responses.
引用
收藏
页码:36148 / 36157
页数:10
相关论文
共 50 条
  • [31] Vascular endothelial growth factor (VEGF-A) in Fabry disease correlation with the cutaneous and the systemic manifestations with vascular involvement
    Zampetti, Anna
    Gnarra, Maria
    Giurdanella, Federica
    Borsini, Walter
    Antuzzi, Daniela
    Smaldone, Costantino
    Pieroni, Maurizio
    Cadeddu, Chiara
    de Waure, Chiara
    Ferri, Lorenzo
    Morrone, Amelia
    Feliciani, Claudio
    [J]. MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S100 - S101
  • [32] Vascular Endothelial Growth Factor (VEGF-a) in Fabry disease: Association with cutaneous and systemic manifestations with vascular involvement
    Zampetti, Anna
    Gnarra, Maria
    Borsini, Walter
    Giurdanella, Federica
    Antuzzi, Daniela
    Piras, Andrea
    Smaldone, Costantino
    Pieroni, Maurizio
    Cadeddu, Chiara
    de Waure, Chiara
    Feliciani, Claudio
    [J]. CYTOKINE, 2013, 61 (03) : 933 - 939
  • [33] Effects of vascular endothelial growth factor (VEGF) on cultured rat sinusoidal endothelial cells
    Shakado, S
    Sakisaka, S
    Noguchi, K
    Harada, M
    Maekawa, R
    Sata, M
    Tanikawa, K
    [J]. CELLS OF THE HEPATIC SINUSOID, VOL 6, 1997, : 79 - 81
  • [34] Enhancement of muscle regeneration using vascular endothelial growth factor (VEGF) and endothelial cells
    Nomi, M
    Soker, S
    Decoppi, P
    Yoo, JJ
    Atala, A
    [J]. JOURNAL OF UROLOGY, 2003, 169 (04) : 317 - 318
  • [35] Enhancement of muscle regeneration using vascular endothelial growth factor (VEGF) and endothelial cells
    Nomi, M
    Soker, S
    Delo, D
    Eberli, D
    De Coppi, P
    Yoo, JJ
    Atala, A
    [J]. FASEB JOURNAL, 2005, 19 (04) : A486 - A487
  • [36] Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells
    Albig, AR
    Schiemann, WP
    [J]. DNA AND CELL BIOLOGY, 2004, 23 (06) : 367 - 379
  • [37] Cyclosporine toxicity and vascular endothelial growth factor (VEGF).
    Kubisz, Peter
    Grandtnerova, Barbara
    Laca, Ludovit
    Stasko, Jan
    [J]. BLOOD, 2006, 108 (11) : 58B - 58B
  • [38] Vascular endothelial growth factor (VEGF) is a chemoattractant for vascular smooth muscle cells (SMC).
    Grosskreutz, CL
    AnandApte, B
    Terman, B
    Quinn, TP
    DAmore, PA
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 2133 - 2133
  • [39] Vascular endothelial growth factor (VEGF) and its receptors
    Neufeld, G
    Cohen, T
    Gengrinovitch, S
    Poltorak, Z
    [J]. FASEB JOURNAL, 1999, 13 (01) : 9 - 22
  • [40] Vascular endothelial growth factor (VEGF) in ankylosing spondylitis
    Duftner, C
    Dulak, J
    Goldberger, C
    Weidlinger, F
    Falkenbach, A
    Schirmer, M
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 239 - 239